7711 Carondelet Avenue
499 articles about Centene Corporation
Centene Corporation Announces New Chief Communications Officer
Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced it has named Shannon T. Susko as its Senior Vice President and Chief Communications Officer.
Alice Hm Chen M.D., MPH, Named Executive Forum Co-Chair of the Health Care Payment Learning & Action Network
Centene Corporation announced that Alice Hm Chen, M.D., MPH, Centene's Chief Health Officer, has been appointed as an Executive Forum co-chair of the Health Care Payment Learning & Action Network, an organization of public and private healthcare leaders committed to the use of thought leadership, strategic direction and efforts to accelerate adoption of alternative payment models.
Centene to Present at Bernstein 39th Annual Strategic Decisions Conference
Centene Corporation announced it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Friday, June 2, 2023, in New York City.
Centene Corporation Signs Definitive Agreement to Divest Apixio to New Mountain Capital
Centene Corporation announced that it has signed a definitive agreement to sell Apixio, a leading artificial intelligence platform that enables value-based care, to New Mountain Capital, a growth-oriented investment firm with more than $37 billion in assets under management.
Centene Corporation Reports First Quarter 2023 Results
Centene's first quarter results were strong, reflective of continued positive momentum operationally and the beginning of another year of disciplined execution against our strategic framework.
Centene Corporation Names Anika Gardenhire Chief Customer Experience Officer
Centene Corporation announced it has named Anika Gardenhire RN, BSN, MMCI as its Chief Customer Experience Officer.
Centene Announces Changes to Board of Directors - April 03, 2023
Centene Corporation announced that Fred Eppinger will assume the role of Chairman of the Centene Board of Directors, and Wayne DeVeydt will assume the role of Chairman of the Audit and Compliance Committee.
Centene Corporation Schedules 2023 First Quarter Financial Results Conference Call
Centene Corporation announced that it will release its 2023 first quarter financial results at approximately 6 a.m. on Tuesday, April 25, 2023, and will host a conference call afterwards at approximately 8:30 a.m. to review the results.
Centene Recognized by Fortune as One of "America's Most Innovative Companies"
Centene Corporation announced it has been named one of America's Most Innovative Companies by Fortune magazine.
Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members
Evolent Health, Inc., a health care company that delivers proven value-based specialty care solutions to payers and providers, announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation,.
Centene Corporation Announces New Chief People Officer
Centene Corporation announced the appointment of Tanya McNally to Senior Vice President and Chief People Officer of Centene.
Centene to Present at Barclays 2023 Global Healthcare Conference
Centene Corporation announced it will present at the Barclays 2023 Global Healthcare Conference, to be held Tuesday, March 14-Thursday, March 16, 2023, in Miami Beach, Florida.
CENTENE CORPORATION REPORTS 2022 RESULTS
Centene Corporation (NYSE: CNC) announced today its financial results for the fourth quarter and year ended December 31, 2022.
Centene Completes Divestiture of Magellan Specialty Health
Centene Corporation announced that it has completed the previously announced divestiture of Magellan Specialty Health to Evolent Health, Inc..
Centene Corporation Schedules 2022 Fourth Quarter and Full Year Financial Results Conference Call
Centene Corporation issued a reminder that it will release its 2022 fourth quarter and full year financial results at approximately 6 a.m. on Tuesday, February 7, 2023, and will host a conference call afterwards at approximately 8:30 a.m. to review the results.
CENTENE TO PRESENT AT JP MORGAN 41st ANNUAL HEALTHCARE CONFERENCE
Centene Corporation (NYSE: CNC) announced today it will present at the JP Morgan 41st Annual Healthcare Conference, to be held Monday, January 9-Thursday, January 12, 2023, at the Westin St. Francis in California.
CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE
Centene Corporation (NYSE: CNC) today will host its investor day to outline its 2023 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value.
Centene Corporation Announces Leadership Changes and Appointments for Next Phase of Growth
Centene Corporation announced leadership changes and senior management appointments to position the Company for its next stage of growth.
Centene Corporation to Host Investor Day on December 16, 2022
Centene Corporation announced that it will host an investor day, including a question-and-answer session, on Friday, December 16, 2022.
Centene Completes Divestiture of Magellan Rx
Centene Corporation announced that it has successfully completed the previously announced divestiture of Magellan Rx to Prime Therapeutics LLC.